Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs DOI Creative Commons
Natalia Molchanova, Per Brinch Hansen, Henrik Franzyk

и другие.

Molecules, Год журнала: 2017, Номер 22(9), С. 1430 - 1430

Опубликована: Авг. 29, 2017

The rapid emergence of multidrug-resistant pathogens has evolved into a global health problem as current treatment options are failing for infections caused by pan-resistant bacteria. Hence, novel antibiotics in high demand, and this reason antimicrobial peptides (AMPs) have attracted considerable interest, since they often show broad-spectrum activity, fast killing cell selectivity. However, the therapeutic potential natural AMPs is limited their short plasma half-life. Antimicrobial peptidomimetics mimic structure biological activity AMPs, but display extended stability presence matrices. In present review, focus on developments reported last decade with respect to design, synthesis, cytotoxic side effects well applications anti-infective agents. Specifically, only modular residues connected via amide linkages will be discussed. These comprise classes α-peptoids (N-alkylated glycine oligomers), β-peptoids β-alanine β3-peptides, α/β3-peptides, α-peptide/β-peptoid hybrids, α/γ N-acylated N-aminoethylpeptides (AApeptides), oligoacyllysines (OAKs). Such particular interest due potent versatile convenient optimization assembly standard solid-phase procedures.

Язык: Английский

Chemically modified and conjugated antimicrobial peptides against superbugs DOI
Wenyi Li, Frances Separovic, Neil M. O’Brien‐Simpson

и другие.

Chemical Society Reviews, Год журнала: 2021, Номер 50(8), С. 4932 - 4973

Опубликована: Янв. 1, 2021

Antimicrobial resistance (AMR) is one of the greatest threats to human health that, by 2050, will lead more deaths from bacterial infections than cancer. New antimicrobial agents, both broad-spectrum and selective, that do not induce AMR are urgently required. peptides (AMPs) a novel class alternatives possess potent activity against wide range Gram-negative positive bacteria with little or no capacity AMR. This has stimulated substantial chemical development peptide-based antibiotics possessing improved therapeutic index. review summarises recent synthetic efforts their impact on analogue design as well various applications in AMP development. It includes modifications have been reported enhance including lipidation, glycosylation multimerization through broad application bio-orthogonal chemistry, perspectives direction future research. The subject area primarily next-generation agents rational modification AMPs. further serves guide toward most promising directions this field stimulate scientific attention, new, effective selective solutions for several biomedical challenges which peptidomimetics being applied.

Язык: Английский

Процитировано

351

Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides DOI
Viktória Lázár, Ana Martins, Réka Spohn

и другие.

Nature Microbiology, Год журнала: 2018, Номер 3(6), С. 718 - 731

Опубликована: Май 17, 2018

Язык: Английский

Процитировано

347

Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions DOI Creative Commons

Shireen Mohammad,

Christoph Thiemermann

Frontiers in Immunology, Год журнала: 2021, Номер 11

Опубликована: Янв. 11, 2021

Diet-induced metabolic endotoxemia is an important factor in the development of many chronic diseases animals and man. The gut epithelium efficient barrier that prevents absorption liposaccharide (LPS). Structural changes to intestinal response dietary alterations allow LPS enter bloodstream, resulting increase plasma levels (termed endotoxemia). activates Toll-like receptor-4 (TLR4) leading production numerous pro-inflammatory cytokines and, hence, low-grade systemic inflammation. Thus, can lead several inflammatory conditions. Obesity, diabetes, non-alcoholic fatty liver disease (NAFLD) also cause permeability potential pharmacological interventions could be used reduce inflammation associated with endotoxemia.

Язык: Английский

Процитировано

339

Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria DOI

Hoda Moravej,

Zahra Moravej,

Maryam Yazdanparast

и другие.

Microbial Drug Resistance, Год журнала: 2018, Номер 24(6), С. 747 - 767

Опубликована: Июнь 29, 2018

In recent years, because of increased resistance to conventional antimicrobials, many researchers have started study the synthesis new antibiotics control disease-causing effects infectious pathogens. Antimicrobial peptides (AMPs) are among newest antibiotics; these integral compounds in all kinds organisms and play a significant role microbial ecology, critically contribute innate immunity by destroying invading microorganisms. Moreover, AMPs may encourage cells produce chemokines, stimulate angiogenesis, accelerate wound healing, influence programmed cell death multicellular organisms. Bacteria differ their inherent susceptibility mechanisms when responding antimicrobial AMPs. Generally, development AMP is driven direct competition between bacterial species, host pathogen interactions. Several studies shown diverse AMPs, for example, some bacteria proteases trapping proteins; modify surface charge, change membrane fluidity, activate efflux pumps; species make use biofilms exopolymers, develop sensing systems selective gene expression. A closer understanding help developing novel therapeutic approaches treatment infections caused pathogenic that successful extensive Based on observations, this review discusses properties targeting mechanisms, against

Язык: Английский

Процитировано

338

Antimicrobial peptides under clinical investigation DOI

Hye Been Koo,

Jiwon Seo

Peptide Science, Год журнала: 2019, Номер 111(5)

Опубликована: Июнь 3, 2019

Abstract Overuse of conventional antibiotics as well the slow pace new antibiotic drug development leads to antimicrobial resistance (AMR). Because infections with multi‐drug resistant (MDR) pathogens have become a public health issue, need for novel class is urgent. Recently, peptides (AMPs) emerged promising platform fight against MDR bacteria ensuring broad‐spectrum activity and relatively low emergence. Currently, number AMPs are undergoing clinical preclinical trials various infectious diseases. This review lists 36 (27 9 preclinical) brief information about their origin, structure, mechanism, status. From examples under investigation, we categorized several improvement strategies highlighted directions future design AMPs.

Язык: Английский

Процитировано

331

Reassessing the Host Defense Peptide Landscape DOI Creative Commons
Evan F. Haney, Suzana K. Straus, Robert E. W. Hancock

и другие.

Frontiers in Chemistry, Год журнала: 2019, Номер 7

Опубликована: Фев. 4, 2019

Current research has demonstrated that small cationic amphipathic peptides have strong potential not only as antimicrobials, but also antibiofilm agents, immune modulators, and anti-inflammatories. Although traditionally termed antimicrobial (AMPs) these additional roles prompted a shift in terminology to use the broader term host defense (HDPs) capture multi-functional nature of molecules. In this review, we critically examined role AMPs HDPs infectious diseases inflammation. It is generally accepted are multi-faceted mediators wide range biological processes, with individual activities dependent on their polypeptide sequence. context, explore concept chemical space it applies hypothesize various functions class molecule exist independent overlapping activity landscapes. Finally, outline several emerging highlight how an improved understanding processes can potentially be leveraged more fully realize therapeutic promise HDPs.

Язык: Английский

Процитировано

320

Review: Lessons Learned From Clinical Trials Using Antimicrobial Peptides (AMPs) DOI Creative Commons
Gabrielle S. Dijksteel, Magda M. W. Ulrich, Esther Middelkoop

и другие.

Frontiers in Microbiology, Год журнала: 2021, Номер 12

Опубликована: Фев. 22, 2021

Antimicrobial peptides (AMPs) or host defense protect the against various pathogens such as yeast, fungi, viruses and bacteria. AMPs also display immunomodulatory properties ranging from modulation of inflammatory responses to promotion wound healing. More interestingly, cause cell disruption through non-specific interactions with membrane surface pathogens. This is most likely responsible for low limited emergence bacterial resistance many AMPs. Despite increasing number antibiotic-resistant bacteria potency novel combat pathogens, only a few are in clinical use. Therefore, current review describes (i) potential alternatives antibiotics, (ii) challenges toward implementation (iii) strategies improve success rate trials, emphasizing lessons we could learn these trials.

Язык: Английский

Процитировано

298

Membrane targeting cationic antimicrobial peptides DOI

Daniela Ciumac,

Haoning Gong, Xuzhi Hu

и другие.

Journal of Colloid and Interface Science, Год журнала: 2018, Номер 537, С. 163 - 185

Опубликована: Ноя. 2, 2018

Язык: Английский

Процитировано

294

Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance DOI Creative Commons
Réka Spohn, Lejla Daruka, Viktória Lázár

и другие.

Nature Communications, Год журнала: 2019, Номер 10(1)

Опубликована: Окт. 4, 2019

Abstract Antimicrobial peptides (AMPs) are promising antimicrobials, however, the potential of bacterial resistance is a major concern. Here we systematically study evolution to 14 chemically diverse AMPs and 12 antibiotics in Escherichia coli . Our work indicates that against certain AMPs, such as tachyplesin II cecropin P1, limited. Resistance level provided by point mutations gene amplification very low antibiotic-resistant bacteria display no cross-resistance these AMPs. Moreover, genomic fragments derived from wide range soil confer detectable when introduced into native host on plasmids. We have found simple physicochemical features dictate propensity evolve could serve source for development new AMP-based therapeutics less prone resistance, feature necessary avoid any possible interference with our innate immune system.

Язык: Английский

Процитировано

283

Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections DOI Creative Commons
Yuxuan Ma, Chenyu Wang, Yuanyuan Li

и другие.

Advanced Science, Год журнала: 2019, Номер 7(1)

Опубликована: Дек. 5, 2019

ESKAPE pathogens (

Язык: Английский

Процитировано

276